There are few patient- or public-facing tools for longitudinal and comprehensive symptom assessment, especially when faced with an uncharacterized condition such as COVID-19 or a chronic condition in which symptoms have not been adequately specified. To address this need, we developed the Symptom Discovery mobile application and tested its feasibility with the US public early in the COVID-19 pandemic. Although there were challenges, results showed feasibility and acceptance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3233/SHTI231020 | DOI Listing |
Publication Analysis
Top Keywords
longitudinal comprehensive
8
feasibility "symptom
4
"symptom discovery"
4
discovery" longitudinal
4
comprehensive data
4
data collection
4
collection tool
4
tool covid-19
4
covid-19 patient-
4
patient- public-facing
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!